8 results
10-Q
2024 Q1
GUTS
Fractyl Health, Inc. Common Stock
13 May 24
Quarterly report
4:06pm
the sale of the product in that country. Adverse pricing limitations may hinder our ability to recoup our investment in one or more product candidates
10-K
2023 FY
GUTS
Fractyl Health, Inc. Common Stock
1 Apr 24
Annual report
7:15am
of the product in that country. Adverse pricing limitations may hinder our ability to recoup our investment in one or more product candidates, even
424B4
GUTS
Fractyl Health, Inc. Common Stock
2 Feb 24
Prospectus supplement with pricing info
4:18pm
the revenue, if any, we are able to generate from the sale of the product in that country. Adverse pricing limitations may hinder our ability to recoup our
S-1/A
GUTS
Fractyl Health, Inc. Common Stock
29 Jan 24
IPO registration (amended)
6:09am
in that country. Adverse pricing limitations may hinder our ability to recoup our investment in one or more product candidates, even if such product
S-1
c3voiymudkhuukki3b
14 Dec 23
IPO registration
3:39pm
DRS/A
h79qdx5h8o0kn
21 Sep 23
Draft registration statement (amended)
12:00am
DRS/A
m902za8vw4 7qu
22 Aug 23
Draft registration statement (amended)
12:00am
- Prev
- 1
- Next